La cadena de opciones muestra datos clave de las opciones de acciones de SI-BONE a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para SI-BONE..

SI-BONE (NASDAQ:SIBN) Bolsa, Cadena de Opciones

SI-BONE

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEON

ANIP

BBAI

BLRX

CFFI

DOYU

GCTK

LUXH

PMAX

QUBT

RIME

SANG

SIBN

SLXN

SOBR

SONM

TNXP

WHLR

TSMC y otras acciones destacaron en el premercado tras reportar ganancias récord. Descubre los mayores ganadores y perdedores.

Acciones de Taiwan Semiconductor (TSM) suben alrededor del 5%; 20 acciones en movimiento en el premercado de EE.UU.

SI-BONE Inc

Health Care

Press Releases

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

General

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

Earnings

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024

SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025

Bruker Appoints Laura Francis to its Board of Directors

BRKR

PGNY

SWAV

AngioDynamics

Artivion

Alphatec Holdings

AtriCure

Axogen

Beta Bionics

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

ClearPoint Neuro

Conmed

CVRx

Delcath Systems

Paragon 28

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

NeuroPace

Orthofix Medical

Omnicell

Pulse Biosciences

Senseonics Holdings

Semler Scientific

Surmodics

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

Varex Imaging

ZimVie

Needham

Truist Securities

Morgan Stanley

JMP Securities

Piper Sandler

Comments

SI-BONE

SI-BONE (SIBN) Opciones

SI-BONE (NASDAQ:SIBN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL